Regulus Therapeutics Inc. (NASDAQ:RGLS) Q4 2022 Earnings Conference Call March 10, 2022 5:00 PM ET Company Participants Cris Calsada - Chief Financial Officer Jay Hagan - President and Chief Executive Officer Denis Drygin - Chief Scientific Officer Conference Call Participants Brian Cheng - Cantor Fitzgerald Yi Chen - H.C. Wainwright Operator Ladies and gentlemen thank you for standing by and welcome to the Regulus Therapeutics Q4 2021 Conference Call. [Operator Instructions] IÂ'd now like to turn the confe ...